In vitro Assessment of Aortic Regurgitation Using Four-Dimensional Flow Magnetic Resonance Imaging
February 25th, 2022
3.4K views
Aortic regurgitation is an aortic valve heart disease. This manuscript demonstrates how four-dimensional flow magnetic resonance imaging can evaluate aortic regurgitation using in vitro heart valves mimicking aortic regurgitation.
Overview
This study demonstrates the use of four-dimensional flow magnetic resonance imaging (4D flow MRI) to evaluate aortic regurgitation through in vitro heart valve models. The protocol outlines the steps for creating and analyzing these models, providing insights into valvular disease characteristics.
Key Study Components
Area of Science
- Cardiovascular Imaging
- Valvular Heart Disease
- Magnetic Resonance Imaging
Background
- Aortic regurgitation is a significant heart valve disorder.
- In vitro studies can provide detailed insights that in vivo studies may not capture.
- 4D flow MRI allows for comprehensive analysis of blood flow dynamics.
- Understanding MRI data can be challenging for researchers.
Purpose of Study
- To evaluate aortic regurgitation using advanced imaging techniques.
- To enhance the understanding of valvular diseases through in vitro models.
- To provide a detailed protocol for researchers to replicate the study.
Methods Used
- Creation of 3D models of heart valves using CAD software.
- Fabrication of models using CNC machining and 3D printing.
- Setup of an experimental system with a heart simulation pump and MRI.
- Analysis of flow dynamics using 4D flow MRI and DICOM image processing.
Main Results
- Successful creation of in vitro heart valve models.
- Detailed flow dynamics were captured using 4D flow MRI.
- Data processing techniques were developed for analyzing MRI results.
- Insights into the characteristics of aortic regurgitation were obtained.
Conclusions
- The protocol provides a valuable resource for studying aortic regurgitation.
- 4D flow MRI is an effective tool for evaluating valvular diseases.
- In vitro models can enhance understanding of complex cardiovascular conditions.
Frequently Asked Questions
What is aortic regurgitation?
Aortic regurgitation is a condition where the aortic valve does not close properly, allowing blood to flow backward into the heart.
How does 4D flow MRI work?
4D flow MRI captures time-resolved three-dimensional velocity fields of blood flow, providing detailed insights into hemodynamics.
What are the benefits of using in vitro models?
In vitro models allow for controlled experimentation and detailed analysis of specific conditions without the variability of in vivo studies.
What software is used for data analysis?
ITK-SNAP and MATLAB are commonly used for processing and analyzing MRI data.
Can this protocol be applied to other valvular diseases?
Yes, the methodology can be adapted for studying various valvular diseases beyond aortic regurgitation.
What challenges do researchers face with MRI data?
Understanding and interpreting complex MRI images can be difficult, especially for those new to the technology.
Executive Industry Relevance
Quantitative assessment of aortic regurgitation using four-dimensional flow MRI in engineered in vitro models addresses a critical gap in validating imaging-based biomarkers for cardiovascular device and drug development. This approach enables precise measurement of regurgitant flow dynamics, supporting mechanistic de-risking and predictive confidence in early-stage cardiovascular research. The platform's adaptability to simulate diverse valvular pathologies enhances its value for translational pipeline integration and cross-study standardization.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of hemodynamic mechanisms underlying valvular dysfunction in a controlled system.
- Supports functional validation of imaging biomarkers for cardiovascular disease models.
- Facilitates mechanistic de-risking by isolating specific valve pathologies and quantifying their impact on flow.
Screening & Assay Development
- Provides a reproducible in vitro platform for standardizing flow-based imaging assays.
- Generates quantitative volumetric and velocity data for assay calibration and validation.
- Enables benchmarking of new MRI sequences or imaging protocols for cardiovascular applications.
Translational & Preclinical Research
- Aligns in vitro flow measurements with translational biomarker development for preclinical cardiovascular studies.
- Supports continuity from discovery imaging to preclinical validation by enabling direct comparison of imaging outputs to ground truth flow data.
- Reduces translational risk by providing a modifiable system for simulating disease-relevant hemodynamics.
Pipeline & Workflow Integration
This in vitro 4D flow MRI platform bridges early discovery, assay development, and translational research in cardiovascular R&D pipelines.
- Discovery Biology: Enables hypothesis testing of valve pathology effects on flow and regurgitation.
- Screening: Standardizes quantitative imaging outputs for assay readiness and reproducibility.
- Analytics: Provides volumetric and velocity measurements for robust statistical comparison across models.
- Translational Research: Facilitates alignment of imaging biomarkers with preclinical endpoints in cardiovascular disease models.
- Enterprise Reuse: Offers a flexible, modifiable platform for ongoing validation of imaging technologies and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cardiovascular imaging studies.
- Operational Value: Delivers standardized, reproducible, and scalable in vitro imaging workflows.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling early de-risking of imaging biomarkers.
- Portfolio Impact: Supports risk-adjusted prioritization of cardiovascular imaging and device development programs.
Implementation Considerations
- Requires expertise in 3D modeling, MRI operation, and quantitative image analysis.
- Demands access to MRI-compatible fabrication and imaging infrastructure.
- Necessitates cross-team standardization of imaging parameters and data analysis workflows.
- Adaptable to simulate various valvular pathologies and flow conditions for broader disease modeling.
- Careful selection of imaging parameters is critical to minimize measurement bias and ensure quantitative accuracy.
Biopharma FAQs
Why does null hypothesis testing matter for 4D flow MRI target validation?
Null hypothesis testing enables objective evaluation of whether observed differences in regurgitant flow measurements are statistically significant, supporting robust validation of imaging biomarkers in cardiovascular models.
How does independent variable isolation in valve models fit the discovery pipeline?
Isolating specific valve pathologies in engineered models allows researchers to attribute changes in flow dynamics directly to defined structural alterations, strengthening mechanistic insights and target validation in early discovery.
What do quantitative dependent variable measurements from 4D flow MRI enable?
Quantitative volumetric and velocity data from 4D flow MRI enable precise comparison of regurgitant fractions and flow rates across models, facilitating assay calibration and cross-study reproducibility.
Why are replication requirements critical for cross-functional collaboration in imaging workflows?
Replication ensures that imaging outputs are consistent and reproducible across teams, supporting standardized assay development and reliable data integration in multi-disciplinary cardiovascular R&D projects.
What statistical analysis capabilities are required before implementing 4D flow MRI quantification?
Robust statistical analysis is needed to assess measurement bias, error margins, and reproducibility of regurgitant volume quantification, ensuring data integrity before broader implementation in discovery or translational workflows.
Chapters in this video
0:04
Introduction
1:08
Aortic Root Model Fabrication
2:32
Valve Frame 3D Printing
3:42
Aortic Regurgitation Model Using Expanded Polytetrafluoroethylene (ePTFE)
5:12
MRI Scan and Parameter Selection
6:35
Data Sorting and Correction
7:45
Visualization and Quantification
9:35
Results: Streamline Visualization, Flow Rate, and Stroke Volume Calculations
10:38
Conclusion
